Gepirone Hydrochloride Patent Expiration

Gepirone Hydrochloride is Used for treating major depression with sexual dysfunction or without the risk of sexual dysfunction adverse reactions. It was first introduced by Fabre Kramer Pharmaceuticals Inc in its drug Exxua on Sep 22, 2023.


Gepirone Hydrochloride Patents

Given below is the list of patents protecting Gepirone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Exxua US7538116 Treatment of sexual disorders Sep 02, 2025 Fabre Kramer



Gepirone Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List